ZYMENEX
LIVE

Serial Number

79178656

Owner

Zymenex A/S

Attorney

Eric T. Fingerhut

Filing Date

Jul 16, 2015

Add to watchlist:

No watchlists yet
View on USPTO

ZYMENEX Trademark

Serial Number: 79178656 • Registration: 5088854

ZYMENEX is a trademark filed by Zymenex A/S on July 16, 2015. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 16 (Paper Goods). The application is currently registered and active.

Owner Contact Info

Zymenex A/S (8 trademarks)

Roskildevej 12C

Entity Type: 16

Trademark Details

Filing Date

July 16, 2015

Registration Date

November 29, 2016

Published for Opposition

September 13, 2016

Cancellation Date

July 16, 2025

Goods & Services

Scientific, industrial, biotechnological and biomedical research in the field of porphyria illness, lysosomal enzyme deficiency diseases, and non-bacterial diseases, namely, cancer, respiratory diseases, cardiovascular diseases, neonatal respiratory distress syndrome, enzyme replacement therapy preparations, enzyme replacement therapy products for human use in the treatment of genetic disorders, central nervous system disease and research concerning the medical treatment thereof; computer services, namely, providing a database featuring data in the field of medical research; designing, implementing and maintaining websites for others; computer network design and installation of computer software

Publications, namely, books, magazines, periodicals and manuals in the fields of medicine and health; printed instructional and teaching matter in the fields of medicine and health; printed instructional material and printed treatment guides in the field of medicine and health issues; manuals concerning the installation and maintenance of computer software

Pharmaceutical preparations for the treatment of porphyria illness, lysosomal enzyme deficiency diseases, and non-bacterial diseases, namely, cancer, respiratory diseases, cardiovascular diseases, neonatal respiratory distress syndrome, central nervous system disease and other diseases related thereto; enzymes, enzyme-inhibitors, enzyme co-factors and enzyme preparations, namely, enzyme replacement therapy preparations, enzyme replacement therapy products, namely infusions, liquids, tablets and powders for human use in the treatment of genetic disorders, all for medical purposes for the treatment porphyria illness, lysosomal enzyme deficiency diseases; diagnostic preparations for medical purposes used in the field of human illnesses or deficiencies, namely, porphyria illness, lysosomal enzyme deficiency diseases, and non-bacterial diseases

Surgical and medical apparatus and instruments, namely, syringes and needles for medical purposes, inhalers sold empty and blood testing apparatus for use in the treatment of porphyria illness, lysosomal enzyme deficiency diseases, and non-bacterial diseases

Providing education, training courses and instruction in the fields of medicine and information technology (IT)

Providing medical information via the Internet; providing medical advice regarding personal management of medical conditions; providing medical advice to health professionals regarding medical conditions; providing medical information and medical counselling

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Feb 12, 2026 DENA
DEATH OF INTERNATIONAL REGISTRATION
Feb 12, 2026 DETH
NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Feb 5, 2026 DENA
DEATH OF INTERNATIONAL REGISTRATION
Feb 5, 2026 DETH
TOTAL INVALIDATION PROCESSED BY THE IB
Mar 17, 2024 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Feb 27, 2024 INTS
INVALIDATION PROCESSED
Feb 27, 2024 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Feb 16, 2024 INTR
CANCELLED SECTION 71
Jun 16, 2023 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Nov 29, 2021 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Sep 8, 2017 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Apr 21, 2017 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 1, 2017 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Mar 14, 2017 FICS
FINAL DISPOSITION PROCESSED
Mar 14, 2017 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 28, 2017 FICR
NEW REPRESENTATIVE AT IB RECEIVED
Feb 9, 2017 NREP
REGISTERED-PRINCIPAL REGISTER
Nov 29, 2016 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Oct 21, 2016 OPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 13, 2016 NPUB
PUBLISHED FOR OPPOSITION
Sep 13, 2016 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 24, 2016 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Aug 24, 2016 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 24, 2016 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Aug 10, 2016 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 8, 2016 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 8, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 8, 2016 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Aug 8, 2016 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Aug 4, 2016 GNFN
FINAL REFUSAL E-MAILED
Aug 4, 2016 GNFR
FINAL REFUSAL WRITTEN
Aug 4, 2016 CNFR
ASSIGNED TO EXAMINER
Jul 15, 2016 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 15, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 15, 2016 CRFA
ASSIGNED TO LIE
Jul 11, 2016 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 5, 2016 TROA
REFUSAL PROCESSED BY IB
Jan 22, 2016 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 7, 2016 RFCS
REFUSAL PROCESSED BY MPU
Jan 7, 2016 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 30, 2015 RFCR
NON-FINAL ACTION WRITTEN
Dec 29, 2015 CNRT
APPLICATION FILING RECEIPT MAILED
Dec 29, 2015 MAFR
ASSIGNED TO EXAMINER
Dec 22, 2015 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 22, 2015 NWOS
NEW REPRESENTATIVE AT IB RECEIVED
Dec 18, 2015 NREP
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 17, 2015 REPR